The first thing you notice is the absence of the burn. The mouthwash is cool, a little sweet, with a texture closer to water than the viscous, medicinal wash you remember from childhood. The second thing you notice is the instruction, printed plainly on the bottle and repeated on the website: it is safe to swallow. For a parent watching a child swish and inevitably gulp, this is not a minor feature. It is the entire product.
This is the wedge for MayPall, a Laramie-based oral care startup founded in 2024. In a shelf crowded with natural alternatives, the company is not just selling another fluoride-free, alcohol-free rinse. It is selling the elimination of a specific moment of parental anxiety,the supervised spit,by formulating a mouthwash that does not require it. The product, derived from research on natural antibiofilm compounds in maple sap and green tea, targets families and health-conscious consumers who view the bathroom cabinet with new scrutiny [MayPall, retrieved 2024].
A Formulation Forged in Academia
The company’s credibility is rooted in a university lab, not a marketing department. Co-founder Mark Gomelsky is a professor of molecular biology and director of the microbiology program at the University of Wyoming. The core formulation leverages patent-pending research on maple polyphenols for biofilm prevention, work led by scientist and co-founder Ahmed Elbakush in Gomelsky’s lab [PMC, retrieved 2026]. This academic lineage provides a tangible moat: while many competitors tout "natural" ingredients, MayPall’s claims are backed by specific, published research into how its compounds interact with oral bacteria.
The founding team reflects a blend of science and commercial instinct. Alongside Gomelsky and Elbakush are Leo Gomelsky, a business major serving as co-CEO, and pre-dental student Lucas Wall [Laramie Boomerang, June 2024]. It is a classic university spinout structure,the seasoned researcher, the lab scientist, the business operator, and the end-user advocate,assembled to translate a discovery from petri dish to product page.
The Go-to-Market: Samples and Subscriptions
MayPall’s early playbook is a focused, digital-first push. It sells directly through its own website, offering both one-time purchases and a subscription model for recurring delivery [MayPall, retrieved 2024]. The pricing and volume details are not public, but the subscription option signals an intent to build recurring revenue and habit with families, for whom mouthwash is a steady consumable.
Perhaps more strategically, the company is pursuing a classic seeding strategy within the dental profession. It offers free samples to dental offices, a critical channel for building trust and securing referrals in the oral health space [MayPall, retrieved 2024]. A recommendation from a hygienist carries weight that no Instagram ad can match, especially for a product making safety claims for children.
The company’s early-stage status is underscored by its participation in accelerator programs, having been selected for both the Wyoming Venture Capital (WYVC) Accelerator and the gBETA Wyoming Startup Accelerator [Laramie Boomerang, June 2024] [University of Wyoming, April 2026]. These programs provide mentorship and network access, typical fuel for a pre-institutional venture.
The Competitive Rinse Cycle
MayPall enters a market defined by giants and niche players. The competitive set spans from mass-market staples like Listerine and ACT to natural-focused brands like TheraBreath, Boka, and CloSYS. To stand out, the company must convince customers that its unique formulation offers more than just the absence of alcohol and fluoride.
The table below outlines how MayPall’s stated positioning compares to common attributes in the category.
| Brand | Alcohol-Free | Fluoride-Free | Key Marketing Angle |
|---|---|---|---|
| MayPall | Yes | Yes | Safe to swallow, natural antibiofilm compounds [MayPall, retrieved 2024] |
| Listerine (Zero) | Yes | No | Same germ-kill power, no burn |
| TheraBreath | Yes | Yes | Dentist-formulated, targets bad breath |
| ACT (Kids) | Yes | No | Fluoride rinse for cavity prevention |
| Boka | Yes | Yes | Holistic oral wellness, nano-hydroxyapatite |
Its most credible risk is not competition, but proof. The academic research is a strong foundation, but the path from lab efficacy to widespread consumer trust in a swallowed product is long. The company must navigate:
- Clinical validation. While the underlying science is patented, independent clinical studies demonstrating plaque and gingivitis reduction in humans would be a powerful next step.
- Category education. The "safe to swallow" claim requires explaining why it’s safe, moving the conversation from fear to understanding.
- Scale. As a direct-to-consumer play, customer acquisition costs in the crowded wellness space will test the unit economics of a physical product.
The company’s plausible answer lies in its dual-channel approach. By simultaneously courting consumers online and dental professionals offline, it can build brand legitimacy from the bottom up and the top down simultaneously.
The Next Twelve Months
For a company at this stage, the immediate horizon is defined by validation and velocity. The next milestones are likely to be less about splashy new features and more about foundational market signals.
- Funding. The company has not disclosed institutional funding. A seed round would enable scaling marketing efforts and potentially funding those key clinical studies.
- Retail placement. A move from pure DTC into selective retail partnerships, perhaps in natural grocery or pediatric-focused stores, would test broader consumer appeal.
- Product line extension. The core technology could logically expand into other oral care formats,toothpaste, gels, or lozenges,that also benefit from a swallow-safe promise.
The cultural question MayPall is implicitly answering is one of ritual simplification. For generations, the act of using mouthwash has been defined by a concluding step: the deliberate, sometimes messy, act of spitting. By designing that step away, the company is betting that modern parents, already overloaded with instructions and precautions, will pay for one less thing to monitor. It is a small bet on a minor daily chore. But in the economy of parental mental load, eliminating a single moment of vigilance can feel like a major innovation. The product does not just clean mouths; it quietly proposes that the best health products are the ones that disappear into the routine, requiring no special thought or caution at all.
Sources
- [MayPall, retrieved 2024] Home | Maypall: Natural, Effective, and Safe to Swallow Mouthwash | https://www.maypall.com/
- [Laramie Boomerang, June 2024] Laramie-based MayPall among state startups selected for accelerator | https://www.wyomingnews.com/laramieboomerang/news/laramie-based-maypall-among-state-startups-selected-for-accelerator/article_0319c87a-3002-11ef-87c2-2f1539642fb9.html
- [PMC, retrieved 2026] Patent applications for maple polyphenols in biofilm prevention | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567/
- [University of Wyoming, April 2026] Five Wyoming Startups Chosen for gBETA Wyoming Startup Accelerator | https://www.uwyo.edu/news/2026/04/five-wyoming-startups-chosen-for-gbeta-wyoming-startup-accelerator.html
- [ASCEND2.0 Program, retrieved 2026] University of Wyoming Researcher Selected for ASCEND2.0 Program | https://ascendtwo.org/latest-news/university-of-wyoming-researcher-selected-for-ascend2-0-program-to-advance-safe-antibiofilm-for-childrens-oral-health